EGRX - Eagle Pharmaceuticals Inc
IEX Last Trade
5.13
-0.110 -2.144%
Share volume: 53,661
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.24
-0.11
-2.10%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-09 | 2022-08-09 | 2022-11-09 | 2023-03-23 | 2023-05-09 | 2023-08-08 | |
| Cash flow financing | -11.358 M | -536.000 K | 3.296 M | 2.389 M | 12.646 M | -6.411 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -16.611 M | 42.992 M | -13.237 M | 37.557 M | -33.512 M | -126.000 K | |
| Net income | 44.058 M | -9.450 M | -7.131 M | 8.165 M | 5.750 M | 5.164 M | |
| Depreciation | 908.000 K | 1.634 M | 3.852 M | 5.630 M | 5.560 M | 5.580 M | |
| Changes in inventories | 24.818 M | 57.712 M | 63.855 M | 47.794 M | 44.140 M | 42.482 M | |
| Changes in receivables | 130.858 M | 85.920 M | 96.932 M | 72.439 M | 114.953 M | 115.140 M | |
| Investing Cashflow | -168.000 K | -75.416 M | -11.237 M | -9.000 K | -12.558 M | -6.000 K | |
| Net Borrowings | -60.765 M | -963.000 K | 37.133 M | -6.055 M | 42.931 M | 40.565 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -168.000 K | 0.000 | 0.000 | -10.000 K | -58.000 K | -6.000 K | |
| Cash Change | 69.522 M | 36.562 M | 15.384 M | 55.321 M | 21.897 M | 15.354 M |